Skip to main content

Research Repository

Advanced Search

mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function

Yuan, Ting; Lupse, Blaz; Maedler, Kathrin; Ardestani, Amin

Authors

Ting Yuan

Blaz Lupse

Kathrin Maedler



Abstract

The mechanistic target of rapamycin (mTOR) signaling pathway is an evolutionary conserved pathway that senses signals from nutrients and growth factors to regulate cell growth, metabolism and survival. mTOR acts in two biochemically and functionally distinct complexes, mTOR complex 1 (mTORC1) and 2 (mTORC2), which differ in terms of regulatory mechanisms, substrate specificity and functional outputs. While mTORC1 signaling has been extensively studied in islet/β-cell biology, recent findings demonstrate a distinct role for mTORC2 in the regulation of pancreatic β-cell function and mass. mTORC2, a key component of the growth factor receptor signaling, is declined in β cells under diabetogenic conditions and in pancreatic islets from patients with type 2 diabetes. β cell-selective mTORC2 inactivation leads to glucose intolerance and acceleration of diabetes as a result of reduced β-cell mass, proliferation and impaired glucose-stimulated insulin secretion. Thereby, many mTORC2 targets, such as AKT, PKC, FOXO1, MST1 and cell cycle regulators, play an important role in β-cell survival and function. This indicates mTORC2 as important pathway for the maintenance of β-cell homeostasis, particularly to sustain proper β-cell compensatory response in the presence of nutrient overload and metabolic demand. This review summarizes recent emerging advances on the contribution of mTORC2 and its associated signaling on the regulation of glucose metabolism and functional β-cell mass under physiological and pathophysiological conditions in type 2 diabetes.

Citation

Yuan, T., Lupse, B., Maedler, K., & Ardestani, A. (2018). mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function. Journal of Molecular Biology, 430(7), 904-918. https://doi.org/10.1016/j.jmb.2018.02.013

Journal Article Type Review
Acceptance Date Feb 14, 2018
Online Publication Date Feb 23, 2018
Publication Date Mar 30, 2018
Deposit Date Jan 4, 2024
Journal Journal of Molecular Biology
Print ISSN 0022-2836
Electronic ISSN 1089-8638
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 430
Issue 7
Pages 904-918
DOI https://doi.org/10.1016/j.jmb.2018.02.013
Public URL https://hull-repository.worktribe.com/output/4461638